BioArctic – Talk Bio

Actionable Insights Powered by AI

Novartis Pays $30M Upfront to Leqembi Creator BioArctic for Access to Blood-Brain Barrier Technology

2 months ago talkbio0Tagged Antibodies, BioArctic, Blood - brain barrier anatomy, BrainTransporter platform, Leqembi, milestone payments, Nerve Degeneration, Novartis, Partnership, royalties

Novartis; BioArctic; BrainTransporter platform; blood-brain barrier; neurodegeneration; Leqembi; partnership; antibody; milestone payments; royalties

Bristol Myers Squibb Partners with BioArctic in $100M Alzheimer’s Deal

10 months ago talkbio0Tagged Alzheimer 's disease, BioArctic, Collaboration, Leqembi, Myers, squibb

Bristol Myers Squibb, BioArctic, Leqembi, Alzheimer’s disease, collaboration, $100M upfront payment

Bristol Myers Squibb Invests $100M in BioArctic for Next-Generation Alzheimer’s Therapies

10 months ago talkbio0Tagged Alzheimer 's disease, BAN1503, BAN2803, BioArctic, Leqembi, Myers, preclinical antibodies, squibb

Alzheimer’s disease, Bristol Myers Squibb, BioArctic, Leqembi, preclinical antibodies, BAN1503, BAN2803